Real-world outcome of low-frequency outpatient monitoring for venetoclax initiation in CLL: Single-center experience

Institutions

Publication Details

Journal
Blood
Published
2025-11-03
DOI
https://doi.org/10.1182/blood-2025-7919
Primary Topic
Methemoglobinemia and Tumor Lysis Syndrome
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Real-world outcome of low-frequency outpatient monitoring for venetoclax initiation in CLL: Single-center experience

Blood
Methemoglobinemia and Tumor Lysis Syndrome
article

Real-world outcome of low-frequency outpatient monitoring for venetoclax initiation in CLL: Single-center experience

article en

Abstract

No abstract available for this paper.
BloodVol. 146(Supplement 1)
Northwell Health (US), Hemel Hempstead Hospital (GB)
Good health and well-being
Openalex Percentile: Top 31%
Methemoglobinemia and Tumor Lysis Syndrome
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Real-world outcome of low-frequency outpatient monitoring for venetoclax initiation in CLL: Single-center experience · Blood (2025) | TGRS Research Map | TGRS